These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging. Chong EA, Torigian DA, Mato AR, Downs LH, Schuster SJ. Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570 [No Abstract] [Full Text] [Related]
15. Non-Hodgkin's lymphoma of the bone and the liver without lymphadenopathy revealed on FDG-PET/CT. Cheng G, Servaes S, Chamroonrat W, Li J, Zhuang H. Clin Imaging; 2010 Oct; 34(6):476-9. PubMed ID: 21092880 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus mimicking lymphoma on FDG-PET/CT. Thomas DL, Syrbu S, Graham MM. Clin Nucl Med; 2009 Dec; 34(12):891-3. PubMed ID: 20139824 [Abstract] [Full Text] [Related]
17. Synchronous adenocarcinoma of the appendix demonstrated on F-18 FDG PET/CT. Lu SJ, Osmany S, Khoo JB, Ng DC. Clin Nucl Med; 2010 Apr; 35(4):256-7. PubMed ID: 20305414 [No Abstract] [Full Text] [Related]
18. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B. J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438 [Abstract] [Full Text] [Related]
19. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [Abstract] [Full Text] [Related]
20. Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT. Bertagna F, Sobic-Saranovic D, Obradovic V, Artiko V, Giubbini R, Alavi A. Hell J Nucl Med; 2009 Oct; 12(1):63. PubMed ID: 19330187 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]